Selection of antihypertensive agents in patients at risks for diabetes

Current Hypertension Reports

Volumn 7, Issue 6, 2005, Pages 461-465

  Holcomb, Susan Simmons ^a  

^a Kansas City Kansas Community College ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; LISINOPRIL; LOSARTAN; NISOLDIPINE; PLACEBO; QUINAPRIL; RAMIPRIL; ROSIGLITAZONE; TELMISARTAN; THIAZIDE DIURETIC AGENT; VALSARTAN; VERAPAMIL;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEATH; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EXERCISE; FOLLOW UP; HUMAN; HYPERTENSION; LIFESTYLE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; RISK FACTORS; TREATMENT OUTCOME;

EID: 31344451114     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-005-0042-z     Document Type: Review

References (18)

1. Holcomb SS: Diabetes update: 2005 ACE guidelines. Nurse Pract 2005, 30:12-14.
2. Holcomb SS: Treating hypertension in diabetes patients. Nurse Pract 2004, 29:13-15.
3. National Heart, Lung, and Blood Institute (NHLBI): Complete report: the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2004. http://www.nhlbi.nih.gov/guidelines/hypertension/jncfull.pdf. Accessed June 25, 2005.
4. Magill MK, Gunning K, Saffel-Shrier S, Gay C: New developments in the management of hypertension. Am Fam Phys 2003, 68:853-857.
5. Townsend MS, Fulgoni VL 3rd, Stem JS, et al.: Low mineral intake is associated with high systolic blood pressure in the Third and Fourth National Health and Nutrition Examination Surveys: Could we all be right? Am J Hypertension 2005, 18:261-269.
6. Lopez-Ridaura F, Willett WC, Rimm EB, et al.: Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004, 27:134-139.
7. The DREAM Trial Investigators: Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 2004, 47:1519-1527.
8. Sharma AM, Janke J, Gorzelniak Y, et al.: Angiotensin blockade prevents type 2 diabetes by formation fat cells. Hypertension 2002, 40:609-611.
9. Niklason A, Hedner T, Niskanen L, et al.: Development of diabetes is retarded by ACE inhibition in hypertensive patients: a subanaylsis of the Captopril Prevention Project (CAPP). J Hypertens 2004, 22:645-652.
10. Khan BV, Sola S, Lauten WB, et al.: Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome. Diabetes Care 2004, 27:1712-1715.
11. Ong HT, Cheah JS: Choice of antihypertensive drug in the diabetic patient. Medscape General Medicine 2005, http://www.medscape.com/viewprogram/3989_pnt.
12. Abbott KC, Bakris GL: What have we learned from the current trials? Med Clin North Am 2004, 88:189-207.
13. Vidt DG: The ALLHAT trial: diuretics are still the preferred initial drugs for high blood pressure. Cleveland Clin J Med 2003, 70:263-269.
14. National Heart, Lung, and Blood Institute: ALLHAT information for health professionals: quick reference for health care providers.
15. Lopez-Sendon J, Swedberg K, McMurray J, et al.: Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. http://www.guidelines.gov/summary/sumary.aspx?doc_id=5747&nbr=38. Accessed June 22, 2005.
16. Berra K, Hughes S: Pharmacologic agents to reduce cardiovascular disease risk for the patient with insulin resistance. In Reducing Cardiovascular Risk in the Insulin Resistant Patient. Edited by Lamendola C, Mason CM. New York: Preventive Cardiovascular Nurses Association; 2004:45-65. http://www.nhlbi.nih.gov/health/allhat/qckref.htm. Accessed June 24, 2005.
17. Weiss SV, Mottur-Pilson C: The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. http://www.guidelines.gov/summary/summary.aspx?doc_id=3739&nbr=29. Accessed June 22, 2005.
18. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med 2002, 346:393-403.